A Nomogram for the Prediction of Intermediate Significant Renal Function Loss After Robot-assisted Partial Nephrectomy for Localized Renal Tumors: A Prospective Multicenter Observational Study (RECORd2 Project).

Journal: European urology focus
Published Date:

Abstract

BACKGROUND: Robot-assisted partial nephrectomy (RAPN) is increasingly adopted for the treatment of localized renal tumors; however, rates and predictors of significant renal function (RF) loss after RAPN are still poorly investigated, especially at a long-term evaluation.

Authors

  • Andrea Mari
  • Riccardo Tellini
    Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Alessandro Antonelli
    Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Riccardo Schiavina
    1 Department of Urology, University of Bologna , Bologna, Italy .
  • Daniele Amparore
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Roberto Bertini
    Unit of Urology, Division of Experimental Oncology, URI-Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Eugenio Brunocilla
    1 Department of Urology, University of Bologna , Bologna, Italy .
  • Umberto Capitanio
    Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
  • Enrico Checcucci
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Luigi Da Pozzo
    Department of Urology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Fabrizio Di Maida
    Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
  • Cristian Fiori
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Maria Furlan
    Urology Unit, ASST Spedali Civili Hospital, Department of Medical and Surgical Specialties, Radiological Science, and Public Health, University of Brescia , Italy.
  • Paolo Gontero
    Department of Urology, Molinette Hospital, University of Torino School of Medicine, Turin, Italy.
  • Nicola Longo
    Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II," Naples, Italy.
  • Marco Roscigno
    Department of Urology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Claudio Simeone
    Urology Unit, ASST Spedali Civili Hospital, Department of Medical and Surgical Specialties, Radiological Science, and Public Health, University of Brescia , Italy.
  • Salvatore Siracusano
    Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
  • Vincenzo Ficarra
  • Marco Carini
  • Andrea Minervini
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.